FDA Inspection
James P. Lin, M.D., Inc.James P. Lin, M.D., Inc. – FDA Inspection, Aug 22, 2024
Record Details
This FDA Inspection record concerns James P. Lin, M.D., Inc., with an inspection on August 22, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e757db1e-9818-413c-a4c6-0b8a1b57a309
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1247157
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.50(b)(1)Donor screening standards
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of James P. Lin, M.D., Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for James P. Lin, M.D., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.